Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $83.30 | Total: $416.50 |
| 1 | 10 | $70.56 | Total: $705.60 |
| 1 | 25 | $59.78 | Total: $1,494.50 |
| 1 | 50 | $50.96 | Total: $2,548.00 |
| 1 | 100 | $44.10 | Total: $4,410.00 |
Overview
Kisspeptin-10, human TFA is a potent vasoconstrictor and angiogenesis inhibitor. Kisspeptin-10, human TFA acts as a tumor metastasis suppressor via its receptor GPR54. Kisspeptin-10-GPR54 system plays an important role in embryonic kidney development. Kisspeptin-10GPR54 signaling induces osteoblast differentiation via NFATc4-mediated BMP2 expression
Chemical Properties
| Molecular Formula | C63H83N17O14.C2HF3O2 |
| Molecular Weight | 1416.46 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | CC([H])(C[C@](N=C(CN=C([C@](CC1=CC=CC=C1)(N=C([C@](CO)(N=C([C@](CC(O)=N)(N=C([C@](CC2=CNC3=CC=CC=C23)(N=C([C@](CC(O)=N)(N=C([C@]([H])(CC4=CC=C(C=C4)O)N)O)[H])O)[H])O)[H])O)[H])O)[H])O)O)(C(O)=N[C@@](CCCNC(N)=N)(C(O)=N[C@@](CC5=CC=CC=C5)(C(O)=N)[H])[H])[H])C.O=C(O)C(F)(F)F |
Storage and Handling
0C Short Term, -20C Long Term
References
Son HE, et al. Kisspeptin-10 [KP-10] stimulates osteoblast differentiation through GPR54-mediated regulation of BMP2 expression and activation. Sci Rep. 2018 Feb 1;8[1] 2134.